Shenyang Xingqi Pharmaceutical Co.,Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 349.88 million compared to CNY 286.56 million a year ago. Revenue was CNY 349.88 million compared to CNY 286.56 million a year ago.

Net income was CNY 34.75 million compared to CNY 19.35 million a year ago. Basic earnings per share from continuing operations was CNY 0.28 compared to CNY 0.16 a year ago. Diluted earnings per share from continuing operations was CNY 0.28 compared to CNY 0.16 a year ago.